Basics Humacyte, Inc. Common Stock IPO Date: November 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $353.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.86% Avg Daily Range (30 D): $0.08 | 3.38% Avg Daily Range (90 D): $0.09 | 4.38% Institutional Daily Volume Avg Daily Volume: 1.37M Avg Daily Volume (30 D): 3.13M Avg Daily Volume (90 D): 4.06M Trade Size Avg Trade Size (Sh.): 162 Avg Trade Size (Sh.) (30 D): 241 Avg Trade Size (Sh.) (90 D): 279 Institutional Trades Total Inst.Trades: 292 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $1.75M Avg Inst. Trade (90 D): $1.47M Avg Inst. Trade Volume: .31M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $2.67M Avg Closing Trade (90 D): $1.92M Avg Closing Volume: 314.79K     News Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra Jan 21, 2025 @ 3:44 PM DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ... Source: The Law Offices Of Frank R. Cruz Jan 17, 2025 @ 5:28 PM HUMA Investors Have Opportunity to Lead Humacyte, ... Source: Business Wire Jan 17, 2025 @ 3:47 PM HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM,... Source: N/A Jan 13, 2025 @ 5:14 PM Humacyte, Inc. (HUMA) Investors Who Lost Money Hav... Source: Prnewswire Financials   TTM Q4 2024 FY 2024 Basic EPS $.28 $-.16 $-1.26 Diluted EPS $.28 $-.16 $-1.26 Revenue $ .52M $ M $ M Gross Profit $ .37M $ $ Net Income / Loss $ 39.14M $ -20.94M $ -148.7M Operating Income / Loss $ -23.18M $ -28.09M $ -114.4M Cost of Revenue $ .15M $ $ Net Cash Flow $ 17.91M $ 24.37M $ 14.49M PE Ratio 9.45